Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher urate in LRRK2
mutation carriers resistant to Parkinson disease
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-14
DOI
10.1002/ana.25436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma urate and risk of Parkinson's disease: a Mendelian randomization study
- (2018) Camilla J Kobylecki et al. ANNALS OF NEUROLOGY
- Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease
- (2018) Demis A Kia et al. ANNALS OF NEUROLOGY
- Targeting urate to reduce oxidative stress in Parkinson disease
- (2017) Grace F. Crotty et al. EXPERIMENTAL NEUROLOGY
- Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
- (2017) Annie J. Lee et al. MOVEMENT DISORDERS
- Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
- (2017) Marta San Luciano et al. Annals of Clinical and Translational Neurology
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Prospective study of plasma urate and risk of Parkinson disease in men and women
- (2016) Xiang Gao et al. NEUROLOGY
- Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis
- (2016) Gaia Skibinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
- (2016) Dario C. Angeles et al. Annals of Clinical and Translational Neurology
- LRRK2 Pathways Leading to Neurodegeneration
- (2015) Mark R. Cookson Current Neurology and Neuroscience Reports
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release
- (2015) Rachit Bakshi et al. NEUROBIOLOGY OF DISEASE
- Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
- (2015) Karen Marder et al. NEUROLOGY
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis
- (2013) Liang Shen et al. BMJ Open
- Efficient determination of purine metabolites in brain tissue and serum by high-performance liquid chromatography with electrochemical and UV detection
- (2012) Thomas C. Burdett et al. BIOMEDICAL CHROMATOGRAPHY
- Protection of dopaminergic cells by urate requires its accumulation in astrocytes
- (2012) Sara Cipriani et al. JOURNAL OF NEUROCHEMISTRY
- Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease
- (2012) Sara Cipriani et al. PLoS One
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started